GO
Loading...

Pfizer Inc

More

  • *AbbVie raises bid to 53.20/ share from 51.15. *Bid comprises 24.44 stg cash and 0.8960 new AbbVie shares. LONDON, July 14- London- listed drugmaker Shire Plc succumbed to an increased 31 billion pounds takeover offer from Abbvie Inc on Monday, signaling the conclusion to a long-running courtship largely motivated by tax.

  • UK to demand job assurances in foreign takeovers Sunday, 13 Jul 2014 | 7:36 AM ET
    UK Business Secretary Vince Cable

    Britain is to set out proposals to force foreign buyers of key UK companies to make binding commitments to secure jobs and research budgets.

  • Allergan to shareholders: Ignore Pershing Square Friday, 11 Jul 2014 | 6:31 PM ET
    A vial of Allergan’s Botox is arranged next to boxes for a photograph at a doctor's office in Manhattan Beach, Calif.

    Allergan told its stockholders not to respond to Pershing Square Capital Management's proposal to replace a majority of the board.

  • Midday Glance: Pharmaceuticals companies Friday, 11 Jul 2014 | 1:37 PM ET

    Baxter International Inc. fell$. 54 or. 7 percent, to $76.21. Bristol-Myers Squibb Co. fell$. 07 or. 1 percent, to $48.44. Hospira fell$. 34 or. 7 percent, to $50.72.

  • The Alzheimer's epidemic: Where we stand Friday, 11 Jul 2014 | 11:45 AM ET

    Although treatments for Alzheimer's have struggled, drugmakers are still working in the space, with 67 medicines currently in development.

  • Early Glance: Pharmaceuticals companies Friday, 11 Jul 2014 | 10:30 AM ET

    Baxter International Inc. fell$. 54 or. 7 percent, to $76.21. Bristol-Myers Squibb Co. fell$. 11 or. 2 percent, to $48.40. Hospira fell$. 22 or. 4 percent, to $50.84.

  • Most active New York Stock Exchange-traded stocks Thursday, 10 Jul 2014 | 1:44 PM ET

    NEW YORK— A look at New York Stock Exchange 10 most-active stocks at 1 p.m.:. Advanced Micro Devices Inc. rose 2.6 percent to $4.34 with 28,731,400 shares traded. Alcoa Inc. rose 1.1 percent to $15.86 with 15,807,700 shares traded.

  • Midday Glance: Pharmaceuticals companies Thursday, 10 Jul 2014 | 1:44 PM ET

    Baxter International Inc. rose$. 65 or. 9 percent, to $76.47. Bristol-Myers Squibb Co. rose$. 58 or 1.2 percent, to $48.50. Hospira fell$. 56 or 1.1 percent, to $50.95.

  • Early Glance: Pharmaceuticals companies Thursday, 10 Jul 2014 | 11:01 AM ET

    Baxter International Inc. fell$. 10 or. 1 percent, to $75.72. Bristol-Myers Squibb Co. fell$. 09 or. 2 percent, to $47.83. Hospira fell$. 71 or 1.4 percent, to $50.80.

  • Lightning Round: Pfizer, AT&T & more Wednesday, 9 Jul 2014 | 6:49 PM ET

    It's time for the Lightning Round. Cramer makes the call on viewer favorites.

  • Early movers: AA, TCS, C, B, AAPL, PFE, AMX & more Wednesday, 9 Jul 2014 | 7:33 AM ET
    Traders on the floor of the New York Stock Exchange.

    Some of the names on the move ahead of the open.

  • Maybe those foreign Rx drugs aren't so shady Sunday, 6 Jul 2014 | 11:30 AM ET

    While there are weaknesses in the alternative market of prescription drugs, the risks are not always as serious as some claim.

  • Ordering discount prescriptions? Buyer beware Saturday, 5 Jul 2014 | 12:02 PM ET

    Internet drugstores and their facilitators may claim to be safe, low-cost alternatives to pharmacies. But consumers need to be cautious.

  • Dow 17,000: Who led & lagged the last 1,000 points Thursday, 3 Jul 2014 | 10:20 AM ET
    A trader works on the floor of the New York Stock Exchange.

    The Dow Jones industrial average touched 17,000 for the first time on Thursday, 7 months after the index closed above 16,000 for the first time.

  • A trader works on the floor of the New York Stock Exchange.

    U.S. stocks closed mixed on Wednesday as the Dow and S&P 500 pushed into uncharted territory ahead of a government jobs report.

  • Prescription drugs: Risk vs. cost     Wednesday, 2 Jul 2014 | 1:46 PM ET

    Due to the high cost of prescription drugs, many in the U.S. look overseas to save money. CNBC's Scott Cohn discusses if people are putting themselves at risk or beating big drug companies at their own game.

  • This drug became kosher (but it doesn't matter) Tuesday, 1 Jul 2014 | 4:08 PM ET
    Web page for Pfizer's Elelyso

    Pfizer paid a "nominal fee" to cover expenses related to the facility inspection, and to obtain a certification, a Pfizer spokeswoman said.

  • July 1- Agenus Inc said its experimental cancer vaccine helped brain tumor patients live nearly twice as long compared with those who received standard of care treatment.

  • Walgreens

    Walgreen's chief, who said he was "proud of our Illinois heritage," is considering a deal that would move its HQ to Switzerland in a bid to cut taxes.

  • NEW YORK, June 30- Investor support for large acquisitions and a desire to trump rivals in consolidating markets have led chief executives to strike big transactions so far in 2014, raising year-to-date global deal volumes to their highest level in seven years.